Matthew Smith, MD
Neurocritical Care · Cincinnati, OHNPI 1861879686
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (44.7%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Microvention, Inc. at 43.5% of the total.
Across 17 payments — averaging $127.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Microvention, Inc.$944
- BD$406
- Medtronic$163
- Penumbra, Inc.$146
- AstraZeneca$117
- Lilly USA, LLC$93
- plus $299 from 6 others
What the payments were for
- Consulting fees$40619%
- Travel & lodging$79337%
- Food & beverage$96945%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Microvention, Inc. | 2 | $944 |
| BD | 1 | $406 |
| Medtronic | 2 | $163 |
| Penumbra, Inc. | 1 | $146 |
| AstraZeneca | 1 | $117 |
| Lilly USA, LLC | 3 | $93 |
| Biogen | 1 | $87 |
| Stryker | 2 | $78 |
| Medical Device Business Services, Inc. | 1 | $64 |
| Scientia Vascular | 1 | $33 |
| Teleflex LLC | 1 | $22 |
| AbbVie | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WEB Aneurysm Embolization System$150
- SOFIA 6F-131CM STR$150
- LVIS JUNIOR$150
- ERIC RETRIEVAL DEVICE$150
- RED 72$146
- SOLITAIRE X$146
- ANDEXXA$117
How this compares
$2,168 in reported general payments places this provider in the 80th percentile of 30 neurocritical care providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levetiracetam | 14 | $179 |
| ClopidogrelClopidogrel Bisulfate | 21 | $134 |
Paid to pharmacies, not to this prescriber.
Other neurocritical care in Cincinnati
- John KachorisCincinnati$6K
- Graham GarrisonCincinnati$696
- Christopher ZammitCincinnati$693
- Ren-Shuoh KuoCincinnati$201
- Deep PatelCincinnati$190
- Kiran PoudelCincinnati$145
- David RobinsonCincinnati$126
- Barbara BasilCincinnati$106
- Lachelle VanceCincinnati$59
- Michel TorbeyColumbus$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.